http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012053777-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2db894723623293a79d3dbb1c095f467
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0ca0aa9c9ad1db763f74d96188e00c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_617fa72a58236ccb9685c9ead1f88310
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e7b08c421f7d2a0917a29404415096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_417dd8d2177bef6aa002e367f9fc38b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bc6d7e07cca0c16f01bcf4a891790c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6f3cf41e51d73311549debfbe974691
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y205-01065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54
filingDate 2011-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10102e71efecb7bddceb219b847b9ccb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3535f6da1f9e63205dc908acbc95c715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90507091ae5ab671985c2fd193197d76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_302f687c49079ec286132e680693dfeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bafa592274954fb614917d9cf011a05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55019d3307909a46ce38dc880cd1bff8
publicationDate 2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012053777-A3
titleOfInvention O-phosphoserine sulfhydrylase mutants and method for production of cysteine using the same
abstract Disclosed is an O-phosphoserine sulfhydrylase (OPSS) mutant which has a Mycobacterium smegmatis -derived amino acid sequence corresponding to that of SEQ ID NO: 1 which is devoid of three to seven C-terminal amino acid residues. Also, a nucleic acid molecule encoding the OPSS mutant, an expression vector carrying the nucleic acid molecule, and a transformant transformed with the expression vector are disclosed. In addition, a method is provided for producing cysteine in which O-phospho-L-serine (OPS) is reacted with a sulfide in the presence of the OPSS mutant. The OPSS mutant has improved enzymatic activity and can be applied to the environmentally friendly production of L-cysteine through a simple enzymatic conversion reaction.
priorityDate 2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008311632-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005255568-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481998
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1772

Total number of triples: 35.